Incomplete resolution of basilar artery occlusion after intra-arterial thrombolysis: Abciximab and heparin prevent early rethrombosis [2]

Cerebrovascular Diseases

Volumn 10, Issue 6, 2000, Pages 484-486

  Küker, Wilhelm ^a   Friese, S ^a   Vogel, W ^a   Schmidt, F ^a   Weller, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; HEPARIN; UROKINASE;

BASILAR ARTERY; BLOOD CLOT LYSIS; CASE REPORT; CORONARY ARTERY RECANALIZATION; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; TREATMENT OUTCOME;

EID: 0033772958     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016115     Document Type: Letter

References (7)

1. Intra-arterial thrombolysis in acute basilar artery thromboembolism: The initial Mayo Clinic experience
2. Local intra-arterial fibrinolytic therapy in patients with stroke: Urokinase versus recombinant tissue plasminogen activator (r-TPA)
3. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
4. Concept and clinical application of platelet glycoprotein IIb/IIIa inhibition with abciximab (c7E3 fab; Reo-Pro) for the prevention of acute ischemic syndromes
5. Basilar artery rethrombosis: Successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor
6. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization
7. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous revascularization